Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $24.83M.
ENTERPRISE VALUE (EV)
$24.83M
INmune Bio, Inc.
Market Cap
$49.58M
Enterprise Value (EV)
$24.83M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| INmune Bio, Inc. (INMB) | $49.58M | $24.83M |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | $34.71M |
| Apollomics, Inc. (APLM)vs › | $49.37M | $46.73M |
| Microbot Medical Inc. (MBOT)vs › | $49.23M | $46.96M |
| TELA Bio, Inc. (TELA)vs › | $49.21M | $75.40M |
| Celularity Inc. (CELU)vs › | $48.92M | $108.85M |
| Envoy Medical, Inc. (COCH)vs › | $50.56M | $31.69M |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.43M | $42.65M |
| Lite Strategy, Inc. (LITS)vs › | $48.15M | $42.44M |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.33M | N/A |
Market Cap
$49.58M
Total Debt
$0.00
Cash
$24.75M
Enterprise Value
$24.83M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
